
Bioxodes
Operator of a clinical-stage biopharmaceutical company intended to prevent and treat thrombotic and inflammatory diseases. The company's platform prevents blood clot formation without increasing the r...
Valuation
$115.5M
Latest known
Share Price
N/A
Total Raised
$39.1M
Last Round
N/A